Related Experiment Videos
Early onset symptomatic neuropathy in a child with Type 1 Diabetes mellitus
Obeid Mohammad Shafi1, Muzamil Latief2
1Department of Paediatrics, Flushing Hospital Medical Center, 4500 Parsons Blvd, Flushing, New York, 11355, USA.
Insights
Diabetic neuropathy (DN) in Type 1 Diabetes Mellitus (T1DM) can appear early, even in adolescence. Current screening guidelines for DN may need earlier implementation, potentially using Nerve Conduction Studies (NCS).
Area of Science:
- Endocrinology
- Neurology
- Pediatrics
Background:
- Diabetic neuropathy (DN) is a significant complication of Type 1 Diabetes Mellitus (T1DM).
- It often presents subclinically in childhood but can lead to severe impairment in adulthood.
- Current screening guidelines for DN in T1DM pediatric patients are inconsistent.
Observation:
- A case study of an adolescent female with poorly controlled T1DM is presented.
- She developed symptomatic diabetic neuropathy within two years of T1DM diagnosis.
- This occurred as her initial long-term complication.
Findings:
- The early onset of symptomatic DN in this case challenges existing screening timelines.
- Clinical assessment (history, neurological exam) is standard but less sensitive than Nerve Conduction Studies (NCS).
- NCS demonstrate higher sensitivity for detecting early, subclinical diabetic neuropathy.
Implications:
- Existing guidelines for DN screening in T1DM children may require revision to recommend earlier screening.
- Nerve Conduction Studies (NCS) could be a valuable tool for screening high-risk pediatric T1DM patients.
- Earlier detection and intervention for DN in T1DM may prevent long-term complications.
Abstract:
Diabetic neuropathy (DN) is a major complication of Type 1 Diabetes Mellitus (T1DM). It is usually subclinical in childhood, but can cause significant impairment with its progression through to adulthood. Current guidelines vary in their recommendation regarding screening for DN in children with T1DM, with some advocating starting screening 5 years after the diagnosis of T1DM. Clinical assessment comprising of history and neurological examination is the most commonly used method for screening, though Nerve Conduction Studies (NCS) provide better sensitivity in picking up early subclinical diabetic neuropathy. We describe an adolescent female with poorly controlled T1DM, presenting with symptomatic diabetic neuropathy within 2 years of disease onset and as the initial long term complication. Thus, guidelines regarding screening for DN may need revision, to start screening earlier than presently recommended, and NCS could play a prominent role in screening children with significant risk factors for developing DN.